Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
tinelchen 
13.12.20 50%
buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
ElectricPlayer 
12.12.20 50%
buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
ElectricPlayer 
12.12.20 50%
buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
ElectricPlayer 
12.12.20 50%
buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
ElectricPlayer 
12.12.20 50%
sell
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€8.75
12.12.20
-
12.12.21
-2.29%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
Inseego Corp.

Start price
Target price
Perf. (%)
€12.26
12.12.20
-
12.12.21
-54.63%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
Tesla Inc

Start price
Target price
Perf. (%)
€166.97
12.12.20
€183.33
12.12.21
80.18%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 80%
sell
Tesla Inc

Start price
Target price
Perf. (%)
€166.97
12.12.20
€183.33
12.12.21
80.18%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,335.8
12.12.20
-
12.12.21
6.06%
09.01.21

Could be worthwhile Investment >10% per year
Some uniques
Medium risks for its business
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,335.8
12.12.20
-
12.12.21
6.06%
09.01.21

Could be worthwhile Investment >10% per year
Some uniques
Medium risks for its business
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Borgwarner Inc.

Start price
Target price
Perf. (%)
€30.40
12.12.20
-
12.12.21
21.71%
14.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Commando 
12.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
SpringheelJack 
12.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
SpringheelJack 
12.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
buy
Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€9.35
12.12.20
-
12.12.21
18.32%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
FXX 
12.12.20 50%
buy
Home Depot Inc.

Start price
Target price
Perf. (%)
€218.45
12.12.20
-
12.12.21
12.86%
24.03.21

Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
FXX 
12.12.20 0%
buy
Home Depot Inc.

Start price
Target price
Perf. (%)
€218.45
12.12.20
-
12.12.21
12.86%
24.03.21

Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
FXX 
12.12.20 0%
sell
Overstock.com

Start price
Target price
Perf. (%)
€45.56
12.12.20
-
12.12.21
74.51%
08.02.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
12.12.20 50%
sell
vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
nvestor 
12.12.20 50%
sell
Sonoma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.90
12.12.20
€3.00
12.12.21
-8.48%
26.06.21

Risky Investment
Revenue decline > 20% expected
Decining EBIT margin than peer group
EBIT decline > 20% expected
nvestor 
12.12.20 50%